|
[1]
|
Li, Y., Wang, H., Li, X., Li, H., Zhang, Q., Zhou, H., et al. (2019) Disordered Intestinal Microbes Are Associated with the Activity of Systemic Lupus Erythematosus. Clinical Science, 133, 821-838. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Yao, H., Yang, H., Wang, Y., Xing, Q., Yan, L. and Chai, Y. (2022) Gut Microbiome and Fecal Metabolic Alteration in Systemic Lupus Erythematosus Patients with Depression. Frontiers in Cellular and Infection Microbiology, 12, Article 1040211. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kharrazian, D., Herbert, M. and Lambert, J. (2023) The Relationships between Intestinal Permeability and Target Antibodies for a Spectrum of Autoimmune Diseases. International Journal of Molecular Sciences, 24, Article 16352. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
An, J., Liu, Y., Wang, Y., Fan, R., Hu, X., Zhang, F., et al. (2022) The Role of Intestinal Mucosal Barrier in Autoimmune Disease: A Potential Target. Frontiers in Immunology, 13, Article 871713. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Ünal, A. and Ülfer, G. (2024) Assessment of Serum Zonulin Levels in Individuals Diagnosed with Chronic Spontaneous Urticaria. Annals of Dermatology, 36, 231-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Mu, Q., Kirby, J., Reilly, C.M. and Luo, X.M. (2017) Leaky Gut as a Danger Signal for Autoimmune Diseases. Frontiers in Immunology, 8, Article 598. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Fasano, A. (2012) Intestinal Permeability and Its Regulation by Zonulin: Diagnostic and Therapeutic Implications. Clinical Gastroenterology and Hepatology, 10, 1096-1100. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zengil, S. and Laloğlu, E. (2024) Evaluation of Serum Zonulin and Occludin Levels in Obsessive-Compulsive Disorder and the Effect of Major Depressive Disorder Comorbidity. Frontiers in Psychiatry, 15, Article 1395235. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wood Heickman, L.K., DeBoer, M.D. and Fasano, A. (2020) Zonulin as a Potential Putative Biomarker of Risk for Shared Type 1 Diabetes and Celiac Disease Autoimmunity. Diabetes/Metabolism Research and Reviews, 36, e3309. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Tripathi, A., Lammers, K.M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M.S., et al. (2009) Identification of Human Zonulin, a Physiological Modulator of Tight Junctions, as Prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America, 106, 16799-16804. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gajda, A.M. and Storch, J. (2015) Enterocyte Fatty Acid-Binding Proteins (FABPs): Different Functions of Liver and Intestinal FABPs in the Intestine. Prostaglandins, Leukotrienes and Essential Fatty Acids, 93, 9-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sturgeon, C. and Fasano, A. (2016) Zonulin, a Regulator of Epithelial and Endothelial Barrier Functions, and Its Involvement in Chronic Inflammatory Diseases. Tissue Barriers, 4, e1251384. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
He, Z., Shao, T., Li, H., Xie, Z. and Wen, C. (2016) Alterations of the Gut Microbiome in Chinese Patients with Systemic Lupus Erythematosus. Gut Pathogens, 8, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gui, L., Zuo, X., Feng, J., Wang, M., Chen, Z., Sun, Y., et al. (2024) Outgrowth of Escherichia Is Susceptible to Aggravation of Systemic Lupus Erythematosus. Arthritis Research & Therapy, 26, Article No. 191. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Shawki, A. and McCole, D.F. (2017) Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli. Cellular and Molecular Gastroenterology and Hepatology, 3, 41-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, Y., Chen, S., Chen, S., Du, J., Lin, J., Qin, H., et al. (2018) Long Noncoding RNA Expression Profile and Association with SLEDAI Score in Monocyte-Derived Dendritic Cells from Patients with Systematic Lupus Erythematosus. Arthritis Research & Therapy, 20, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
van Vollenhoven, R.F., Kalunian, K.C., Dörner, T., Hahn, B.H., Tanaka, Y., Gordon, R.M., et al. (2022) Phase 3, Multicentre, Randomised, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ustekinumab in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 81, 1556-1563. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Bowes, M.M., Casares-Marfil, D. and Sawalha, A.H. (2024) Intestinal Permeability Correlates with Disease Activity and DNA Methylation Changes in Lupus Patients. Clinical Immunology, 262, Article ID: 110173. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Pellicano, C., Oliva, A., Colalillo, A., Gigante, A., D’Aliesio, E., Al Ismail, D., et al. (2024) Serum Markers of Microbial Translocation and Intestinal Damage in Assessment of Gastrointestinal Tract Involvement in Systemic Sclerosis. Clinical and Experimental Medicine, 24, Article No. 225. [Google Scholar] [CrossRef] [PubMed]
|